STAT+: Pharmalittle: AbbVie To Lift $2B Cap On Deals As Humira Rivals Appear; India To Spend $80M To Bolster Regulatory System
India will spend $79.6 million on strengthening its drug regulatory system after the WHO raised concerns about domestically produced cough syrups being linked children's deaths.